Study explores potential first-in-class treatment for common form of fatty liver disease
Research led by Vassilios Papadopoulos, DPharm, PhD, dean of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, indicates that a cholesterol-binding protein may be the key to stopping a subtype of nonalcoholic fatty liver … Read More »